title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Eli Lilly  ( LLY )  Gets FDA Nod for Alzheimer's Drug Donanemab,20240703T123400,https://www.zacks.com/stock/news/2296481/eli-lilly-lly-gets-fda-nod-for-alzheimers-drug-donanemab,LLY,0.219809,Neutral,0.047636
Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?,20240619T170000,https://www.zacks.com/stock/news/2290613/can-eli-lilly-etfs-surge-on-approval-of-alzheimers-drug,LLY,0.405215,Somewhat-Bullish,0.198809
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab  ( Revised ) ,20240614T152100,https://www.zacks.com/stock/news/2288637/alzheimers-in-focus-as-fda-panel-endorses-lillys-donanemab-revised,LLY,0.195025,Somewhat-Bullish,0.185819
"The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune  ( Revised ) ",20240614T151000,https://www.zacks.com/stock/news/2288638/the-zacks-analyst-blog-highlights-biogen-eli-lillys-prothena-and-ac-immune-revised,LLY,0.176502,Neutral,0.142834
"The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune",20240613T100900,https://www.zacks.com/stock/news/2287623/the-zacks-analyst-blog-highlights-biogen-eli-lillys-prothena-and-ac-immune,LLY,0.18046,Neutral,0.145093
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab,20240612T142200,https://www.zacks.com/stock/news/2287324/alzheimers-in-focus-as-fda-panel-endorses-lillys-donanemab,LLY,0.199859,Somewhat-Bullish,0.189231
Is it a Good Idea to Invest in AC Immune  ( ACIU )  Stock Now?,20231205T105900,https://www.zacks.com/stock/news/2193345/is-it-a-good-idea-to-invest-in-ac-immune-aciu-stock-now,LLY,0.213674,Neutral,0.050324
"Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others - Biogen  ( NASDAQ:BIIB ) ",20231121T201625,https://www.benzinga.com/general/biotech/23/11/35901610/alzheimers-disease-vaccines-promising-developments-renewed-enthusiasm-from-biogen-eli-lilly-and-o,LLY,0.229149,Neutral,-0.07556
Biogen  ( BIIB )  & Eisai's Lecanemab Secures EMA's MAA Acceptance,20230127T145700,https://www.zacks.com/stock/news/2045510/biogen-biib-eisais-lecanemab-secures-emas-maa-acceptance,LLY,0.239305,Somewhat-Bullish,0.187879
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win - Biogen  ( NASDAQ:BIIB ) ,20220928T201722,https://www.benzinga.com/general/biotech/22/09/29061026/these-stocks-are-on-the-radar-after-biogen-eisais-surprising-alzheimers-trial-win,LLY,0.112269,Neutral,0.0
"Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecast - Applied DNA Sciences  ( NASDAQ:APDN ) , Eli Lilly  ( NYSE:LLY ) ",20241030T190040,https://www.benzinga.com/markets/equities/24/10/41634156/crude-oil-gains-over-2-eli-lilly-cuts-2024-forecast,LLY,0.269033,Neutral,0.079777
"Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs - bluebird bio  ( NASDAQ:BLUE ) , Amgen  ( NASDAQ:AMGN ) ",20230310T181042,https://www.benzinga.com/general/biotech/23/03/31300483/hefty-listing-price-of-new-drugs-for-cancer-rare-diseases-put-pressure-on-annual-hike-for-older-d,LLY,0.210274,Neutral,0.013086
"Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate - Aquestive Therapeutics  ( NASDAQ:AQST ) ",20240930T182549,https://www.benzinga.com/analyst-ratings/analyst-color/24/09/41101457/optimism-around-aquestive-as-it-moves-forward-with-severe-allergy-baldness-candidat,LLY,0.176502,Neutral,0.010465
Eli Lilly  ( LLY )  Stock Up 57% in 2023: Will the Uptrend Continue?,20240102T134300,https://www.zacks.com/stock/news/2204399/eli-lilly-lly-stock-up-57-in-2023-will-the-uptrend-continue,LLY,0.598368,Bullish,0.380988
APG: 3 Smart Money Stocks to Invest in Today,20230530T125256,https://stocknews.com/news/apg-amph-aqst-3-smart-money-stocks-to-invest-in-today/,LLY,0.081737,Somewhat-Bullish,0.16291
"Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket - AIM ImmunoTech  ( AMEX:AIM ) , Acumen Pharmaceuticals  ( NASDAQ:ABOS ) ",20220928T111722,https://www.benzinga.com/news/22/09/29048520/why-mindmed-is-trading-lower-by-around-35-here-are-31-stocks-moving-premarket,LLY,0.102013,Somewhat-Bullish,0.182345
"Silence Therapeutics  ( NASDAQ:SLN ) , Alnylam Pharmaceuticals  ( NASDAQ:ALNY ) , Eli Lilly  ( NYSE:LLY ) , Amryt Pharma  ( NASDAQ:AMYT ) , SCYNEXIS  ( NASDAQ:SCYX ) , SINTX Technologies  ( NASDAQ:SINT ) , Ocuphire Pharma  ( NASDAQ:OCUP ) , Regeneron Pharmaceuticals  ( NASDAQ:REGN ) , VistaGen Therapeutics  ( NASDAQ:VTGN ) , Axsome Therapeutics  ( NASDAQ:AXSM ) , Lyra Therapeutics  ( NASDAQ:LYRA ) , Revance Therapeutics  ( NASDAQ:RVNC )  - Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary",20220908T221721,https://www.benzinga.com/general/biotech/22/09/28804732/important-biotech-catalysts-for-september-8-2022-end-of-the-day-summary,LLY,0.132611,Neutral,0.116298
Why Is Incyte  ( INCY )  Up 2.1% Since Last Earnings Report?,20241128T163138,https://www.zacks.com/stock/news/2376668/why-is-incyte-incy-up-21-since-last-earnings-report,LLY,0.113776,Neutral,0.044257
"INCY Q3 Earnings Miss Estimates, Revenues Beat on Higher Product Sales",20241029T144700,https://www.zacks.com/stock/news/2359805/incy-q3-earnings-miss-estimates-revenues-beat-on-higher-product-sales,LLY,0.177802,Neutral,0.051155
MacroGenics'  ( MGNX )  Shares Jump 19% in One Week: Here's Why,20230814T151900,https://www.zacks.com/stock/news/2136295/macrogenics-mgnx-shares-jump-19-in-one-week-heres-why,LLY,0.219809,Neutral,0.085665
"ImmunoGen  ( IMGN )  Q1 Earnings Beat, Elahere Uptake Encouraging",20230501T150000,https://www.zacks.com/stock/news/2087582/immunogen-imgn-q1-earnings-beat-elahere-uptake-encouraging,LLY,0.146692,Somewhat-Bullish,0.185723
"ImmunoGen  ( IMGN )  Q3 Loss Wider, Sales Beat, '22 View Up",20221107T190700,https://www.zacks.com/stock/news/2014969/immunogen-imgn-q3-loss-wider-sales-beat-22-view-up,LLY,0.141726,Somewhat-Bullish,0.154966
"Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know - iShares Biotechnology ETF  ( NASDAQ:IBB ) , BondBloxx ETF Trust BondBloxx BB-Rated USD High Yield Corporate Bond ETF  ( ARCA:XBB ) ",20221101T200154,https://www.benzinga.com/general/biotech/22/11/29508633/provention-bios-second-try-apelliss-eye-disorder-drug-review-3-adcom-verdicts-and-more-novembers-,LLY,0.062761,Neutral,-0.02805
Eli Lilly and Company  ( LLY )  Q3 2022 Earnings Call Transcript,20221101T210036,https://www.fool.com/earnings/call-transcripts/2022/11/01/eli-lilly-and-company-lly-q3-2022-earnings-call-tr/,LLY,0.08104,Neutral,0.106838
